These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 8348069
1. Second malignancies following treatment in non-Hodgkin's lymphoma. Ellis M, Lishner M. Leuk Lymphoma; 1993 Mar; 9(4-5):337-42. PubMed ID: 8348069 [Abstract] [Full Text] [Related]
2. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. Travis LB, Weeks J, Curtis RE, Chaffey JT, Stovall M, Banks PM, Boice JD. J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772 [Abstract] [Full Text] [Related]
3. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV). Wheeler C, Khurshid A, Ibrahim J, Elias A, Mauch P, Ault K, Antin J. Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523 [Abstract] [Full Text] [Related]
9. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma. Jang GD, Kim SW, Suh CW, Kim EK, Bahng HS, Jeong YH, Park IG, Kim WK, Kim SH, Suh EJ, Park CJ, Ji HS, Lee JS. J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056 [Abstract] [Full Text] [Related]
10. Risk of leukemia following treatment for non-Hodgkin's lymphoma. Travis LB, Curtis RE, Stovall M, Holowaty EJ, van Leeuwen FE, Glimelius B, Lynch CF, Hagenbeek A, Li CY, Banks PM. J Natl Cancer Inst; 1994 Oct 05; 86(19):1450-7. PubMed ID: 8089863 [Abstract] [Full Text] [Related]
11. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation. Sobecks RM, Le Beau MM, Anastasi J, Williams SF. Bone Marrow Transplant; 1999 Jun 05; 23(11):1161-5. PubMed ID: 10382956 [Abstract] [Full Text] [Related]
13. Incidence and susceptibility to therapy-related myeloid neoplasms. Leone G, Fianchi L, Pagano L, Voso MT. Chem Biol Interact; 2010 Mar 19; 184(1-2):39-45. PubMed ID: 20026017 [Abstract] [Full Text] [Related]
14. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies. Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C. J Cancer Res Clin Oncol; 1998 Mar 19; 124(3-4):207-14. PubMed ID: 9619748 [Abstract] [Full Text] [Related]
15. [Second neoplasms as a late complication of the treatment of Hodgkin's disease]. Morales MD, González FA, Villegas A, del Potro E, Díaz Mediavilla J, Martínez R, Alvarez A, Colomé JA. Sangre (Barc); 1992 Dec 19; 37(6):429-33. PubMed ID: 1293793 [Abstract] [Full Text] [Related]
16. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma. Friedberg JW. Haematologica; 2008 Mar 19; 93(3):336-8. PubMed ID: 18310538 [No Abstract] [Full Text] [Related]
17. Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. Micallef IN, Lillington DM, Apostolidis J, Amess JA, Neat M, Matthews J, Clark T, Foran JM, Salam A, Lister TA, Rohatiner AZ. J Clin Oncol; 2000 Mar 19; 18(5):947-55. PubMed ID: 10694543 [Abstract] [Full Text] [Related]
18. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF. Ann Oncol; 2002 Mar 19; 13(3):450-9. PubMed ID: 11996478 [Abstract] [Full Text] [Related]
19. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience. Maung SW, Burke C, Hayde J, Walshe J, McDermott R, Desmond R, McHugh J, Enright H. Hematology; 2017 Jul 19; 22(6):341-346. PubMed ID: 28196450 [Abstract] [Full Text] [Related]
20. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Rodriguez MA, Fuller LM, Zimmerman SO, Allen PK, Brown BW, Munsell MF, Hagemeister FB, McLaughlin P, Velasquez WS, Swan F. Ann Oncol; 1993 Feb 19; 4(2):125-31. PubMed ID: 8448080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]